Wang H P, Wu M S, Lin C C, Chang L Y, Kao A W, Wang H H, Lin J T
Department of Emergency Medicine, National Taiwan University Hospital, Taipei.
Gastrointest Endosc. 1998 Aug;48(2):184-9. doi: 10.1016/s0016-5107(98)70161-0.
Anomalous pancreaticobiliary ductal union (APBDU) is associated with different pancreaticobiliary diseases. The aim of this study is to clarify the frequency with which it occurs and its several subtypes in various pancreaticobiliary diseases.
Radiograms of 1752 subjects who underwent endoscopic retrograde cholangiopancreatography were reviewed independently by two endoscopists. APBDU was diagnosed using recently accepted criteria and divided into B-P and P-B subtypes according to the insertion of biliary and pancreatic ducts.
Fifty-nine (8.7%) of 680 subjects with clearly visualized pancreaticobiliary radiograms had APBDU. APBDU was present in 93.8% of patients (15 of 16) with choledochal cyst, 62.5% (5 of 8) with gallbladder cancer, 33.3% (9 of 27) with common bile duct cancer, 50.0% (6 of 12) with gallbladder adenomyomatosis, 13.2% (7 of 53) with biliary pancreatitis, 3.4% (10 of 293) with cholelithiasis, 2.2% (2 of 89) with non-biliary pancreatitis, 2.1% (1 of 47) with hilar cholangiocarcinoma, 1.9% (1 of 54) with pancreatic cancer, and 10.2% (9 of 88) with other miscellaneous disorders. There were 25 patients (42.4%) with the B-P type and 34 patients (57.6%) with the P-B type of APBDU. Patients with choledochal cyst frequently had the B-P type, whereas gallbladder cancer, adenomyomatosis, or biliary pancreatitis frequently coexisted with the P-B type.
APBDU is relatively common in patients undergoing endoscopic retrograde cholangiopancreatography at our center. There are a variety of pancreaticobiliary diseases that are associated with APBDU. Its role in these conditions is uncertain and needs to be further delineated.
胰胆管汇合异常(APBDU)与多种胰胆疾病相关。本研究旨在明确其在各种胰胆疾病中的发生率及其几种亚型。
由两名内镜医师独立回顾1752例行内镜逆行胰胆管造影术患者的造影照片。采用最近公认的标准诊断APBDU,并根据胆管和胰管的汇入情况分为B-P型和P-B型。
在680例胰胆管造影清晰可见的患者中,59例(8.7%)有APBDU。在胆总管囊肿患者中,93.8%(16例中的15例)有APBDU;胆囊癌患者中,62.5%(8例中的5例)有APBDU;胆总管癌患者中,33.3%(27例中的9例)有APBDU;胆囊腺肌增生症患者中,50.0%(12例中的6例)有APBDU;胆源性胰腺炎患者中,13.2%(53例中的7例)有APBDU;胆结石患者中,3.4%(293例中的10例)有APBDU;非胆源性胰腺炎患者中,2.2%(89例中的2例)有APBDU;肝门部胆管癌患者中,2.1%(47例中的1例)有APBDU;胰腺癌患者中,1.9%(54例中的1例)有APBDU;其他杂症患者中,10.2%(88例中的9例)有APBDU。有25例(42.4%)患者为B-P型APBDU,34例(57.6%)患者为P-B型APBDU。胆总管囊肿患者常为B-P型,而胆囊癌、腺肌增生症或胆源性胰腺炎常与P-B型共存。
在我们中心接受内镜逆行胰胆管造影术的患者中,APBDU相对常见。有多种胰胆疾病与APBDU相关。其在这些疾病中的作用尚不确定,需要进一步明确。